Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

NCT02612545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

216

Enrollment

NIH

Sponsor class

Conditions

Acute Falciparum Malaria

Interventions

DRUG: Dihydroartemisinin-piperaquine (DHA-PPQ)
DRUG: Mefloquine (MQ)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)